FCN1 and acute myeloid leukemia: Through meticulous examination across six datasets containing survival data of AML patients, we consistently observed a significant correlation between elevated FCN1 expression and reduced OS in AML cohorts (Figures 6A–C; Supplementary Figure S12A-C).